Cargando…
Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke
Stroke is one of the leading causes of death and disability in adults worldwide, resulting in huge social and financial burdens. Extracts from herbs, especially those used in Chinese medicine, have emerged as new pharmaceuticals for stroke treatment. Here we review the evidence from preclinical stud...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921351/ https://www.ncbi.nlm.nih.gov/pubmed/31571650 http://dx.doi.org/10.4103/1673-5374.265545 |
_version_ | 1783481141723922432 |
---|---|
author | Zhang, Bei Saatman, Kathryn E. Chen, Lei |
author_facet | Zhang, Bei Saatman, Kathryn E. Chen, Lei |
author_sort | Zhang, Bei |
collection | PubMed |
description | Stroke is one of the leading causes of death and disability in adults worldwide, resulting in huge social and financial burdens. Extracts from herbs, especially those used in Chinese medicine, have emerged as new pharmaceuticals for stroke treatment. Here we review the evidence from preclinical studies investigating neuroprotective properties of Chinese medicinal compounds through their application in acute and subacute phases of ischemic stroke, and highlight potential mechanisms underlying their therapeutic effects. It is noteworthy that many herbal compounds have been shown to target multiple mechanisms and in combinations may exert synergistic effects on signaling pathways, thereby attenuating multiple aspects of ischemic pathology. We conclude the paper with a general discussion of the prospects for novel natural compound-based regimens against stroke. |
format | Online Article Text |
id | pubmed-6921351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-69213512019-12-26 Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke Zhang, Bei Saatman, Kathryn E. Chen, Lei Neural Regen Res Review Stroke is one of the leading causes of death and disability in adults worldwide, resulting in huge social and financial burdens. Extracts from herbs, especially those used in Chinese medicine, have emerged as new pharmaceuticals for stroke treatment. Here we review the evidence from preclinical studies investigating neuroprotective properties of Chinese medicinal compounds through their application in acute and subacute phases of ischemic stroke, and highlight potential mechanisms underlying their therapeutic effects. It is noteworthy that many herbal compounds have been shown to target multiple mechanisms and in combinations may exert synergistic effects on signaling pathways, thereby attenuating multiple aspects of ischemic pathology. We conclude the paper with a general discussion of the prospects for novel natural compound-based regimens against stroke. Wolters Kluwer - Medknow 2019-09-26 /pmc/articles/PMC6921351/ /pubmed/31571650 http://dx.doi.org/10.4103/1673-5374.265545 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Zhang, Bei Saatman, Kathryn E. Chen, Lei Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke |
title | Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke |
title_full | Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke |
title_fullStr | Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke |
title_full_unstemmed | Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke |
title_short | Therapeutic potential of natural compounds from Chinese medicine in acute and subacute phases of ischemic stroke |
title_sort | therapeutic potential of natural compounds from chinese medicine in acute and subacute phases of ischemic stroke |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921351/ https://www.ncbi.nlm.nih.gov/pubmed/31571650 http://dx.doi.org/10.4103/1673-5374.265545 |
work_keys_str_mv | AT zhangbei therapeuticpotentialofnaturalcompoundsfromchinesemedicineinacuteandsubacutephasesofischemicstroke AT saatmankathryne therapeuticpotentialofnaturalcompoundsfromchinesemedicineinacuteandsubacutephasesofischemicstroke AT chenlei therapeuticpotentialofnaturalcompoundsfromchinesemedicineinacuteandsubacutephasesofischemicstroke |